Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants.

We have previously identified a Plasmodium falciparum liver stage-specific Ag (LSA-1) found to encode tandem 17 amino acid repeats harboring B cell determinants. Here we extend this study in terms of sequence analysis, protein localization, and immunologic properties. Analysis of the N- and C-terminal regions of LSA-1 from the T9/96 clone reveals high sequence conservation with LSA-1 from NF54. This 200-kDa protein is detected throughout liver schizogony and accumulates in the parasitophorous vacuole space. In our investigation of T and B cell responses to LSA-1, we have focused on both the area of the C-terminal, nonrepetitive "hinge" region and the conserved repetitive region and derived synthetic peptides. These were found to contain major B and T cell determinants. High prevalences and elevated Ab levels to LSA-1, directed primarily, although not exclusively, to the repetitive region, were detected in sera of individuals from one moderately high and two low transmission malaria-endemic areas (prevalences of 97%, 75, and 77%, respectively). In one of these low transmission areas, secretion of the cytokine IFN-gamma, known to inhibit malaria liver stages, and T cell proliferation were detected in PBMC of 22 to 48% and 6 to 20%, respectively, of individuals in response to separate LSA-1 peptides. These results complement the recent finding of conserved CTL epitopes in LSA-1 and support the assertion that immune responses to LS Ag are involved in protection against malaria pre-erythrocytic stages.

[1]  G. Reddy,et al.  Gene sequence tags from Plasmodium falciparum genomic DNA fragments prepared by the "genease" activity of mung bean nuclease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Tartar,et al.  Fast immunopurification of small amounts of specific antibodies on peptides bound to ELISA plates. , 1993, Journal of immunological methods.

[3]  M. Alpers,et al.  Natural antibody responses against the non-repeat-sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein , 1993, Infection and immunity.

[4]  M. Aidoo,et al.  Molecular analysis of the association of HLA-B53 and resistance to severe malaria , 1992, Nature.

[5]  C. Rogier,et al.  Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum. , 1992, Journal of immunology.

[6]  D. Modiano,et al.  In vitro immune recognition of synthetic peptides from the Plasmodium falciparum CS protein by individuals naturally exposed to different sporozoite challenge. , 1992, Immunology letters.

[7]  S. Herrera,et al.  Human recognition of T cell epitopes on the Plasmodium vivax circumsporozoite protein. , 1992, Journal of immunology.

[8]  A. Capron,et al.  T helper cell epitopes of the human immunodeficiency virus (HIV-1) nef protein in rats and chimpanzees. , 1992, Molecular immunology.

[9]  T. Theander,et al.  T‐cell responses in malaria , 1992, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[10]  T. McCutchan,et al.  Two types of sequence polymorphism in the circumsporozoite gene of Plasmodium falciparum. , 1992, Molecular and biochemical parasitology.

[11]  S. Bennett,et al.  The statistical analysis of data from immunoepidemiological studies. , 1992, Journal of immunological methods.

[12]  M. Patarroyo,et al.  Specific interactions of synthetic peptides derived from P. falciparum merozoite proteins with human red blood cells. , 1991, Peptide research.

[13]  M. Hollingdale,et al.  Structure of Plasmodium falciparum liver stage antigen-1. , 1991, Molecular and biochemical parasitology.

[14]  C. Atkinson,et al.  Strain specificity in the liver-stage development of Plasmodium falciparum in primary cultures of new world monkey hepatocytes. , 1991, The American journal of tropical medicine and hygiene.

[15]  C. Mendis,et al.  Clustering of malaria infections within an endemic population: risk of malaria associated with the type of housing construction. , 1991, The American journal of tropical medicine and hygiene.

[16]  J. Meuwissen,et al.  Feeding behaviour and sporozoite ejection by infected Anopheles stephensi. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  A. Suhrbier.  Immunity to the liver stage of malaria. , 1991, Parasitology today.

[18]  A. Capron,et al.  Epitopic characterization and vaccinal potential of peptides derived from a major antigen of Schistosoma mansoni (Sm28 GST). , 1991, Peptide research.

[19]  E. Riley,et al.  The immune recognition of malaria antigens. , 1991, Parasitology today.

[20]  A. Tartar,et al.  Secondary structure and immunogenicity of hybrid synthetic peptides derived from two Plasmodium falciparum pre-erythrocytic antigens. , 1990, Journal of immunology.

[21]  B. Knapp,et al.  Responses of T cells from sensitized donors to recombinant and synthetic peptides corresponding to sequences of the Plasmodium falciparum SERP antigen. , 1990, Immunology letters.

[22]  C. Atkinson,et al.  Non-CS pre-erythrocytic protective antigens. , 1990, Immunology letters.

[23]  A. Geinoz,et al.  Interleukin-2 reverses T cell unresponsiveness to Plasmodium falciparum-antigen in malaria immune subjects. , 1990, Cellular immunology.

[24]  F. Lunel,et al.  Protection against malaria induced by irradiated sporozoites , 1990, The Lancet.

[25]  P. Druilhe,et al.  How to select Plasmodium falciparum pre-erythrocytic antigens in an expression library without defined probe. , 1990, Bulletin of the World Health Organization.

[26]  A. van Belkum,et al.  Plasmodium falciparum: studies on mature exoerythrocytic forms in the liver of the chimpanzee, Pan troglodytes. , 1990, Experimental parasitology.

[27]  V. Fischetti,et al.  Streptococcal M protein: molecular design and biological behavior , 1989, Clinical Microbiology Reviews.

[28]  V. Nussenzweig,et al.  Rationale for the development of an engineered sporozoite malaria vaccine. , 1989, Advances in immunology.

[29]  T. McCutchan,et al.  Mung bean nuclease exhibits a generalized gene-excision activity upon purified Plasmodium falciparum genomic DNA. , 1988, Nucleic acids research.

[30]  R. Coppel,et al.  Antigens with repeated amino acid sequences from the asexual blood stages of Plasmodium falciparum. , 1988, Progress in allergy.

[31]  E. Beachey,et al.  Antigenic variation among group A streptococcal M proteins. Nucleotide sequence of the serotype 5 M protein gene and its relationship with genes encoding types 6 and 24 M proteins. , 1988, The Journal of biological chemistry.

[32]  J. Mornon,et al.  Hydrophobic cluster analysis: An efficient new way to compare and analyse amino acid sequences , 1987, FEBS letters.

[33]  G. Langsley,et al.  A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning , 1987, Nature.

[34]  Myron M. Levine,et al.  Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites , 1987, Nature.

[35]  H. Margalit,et al.  Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. , 1987, Science.

[36]  O. Pradier,et al.  Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection , 1986, Infection and immunity.

[37]  G. Mitchell,et al.  Identification of a particular antigen from a parasite cDNA library using antibodies affinity purified from selected portions of Western blots. , 1986, Journal of immunological methods.

[38]  P. Romero,et al.  Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro. , 1985, Journal of immunology.

[39]  D. Mazier,et al.  Complete development of hepatic stages of Plasmodium falciparum in vitro. , 1985, Science.

[40]  P. Druilhe,et al.  Species- and stage-specific antigens in exoerythrocytic stages of Plasmodium falciparum. , 1984, The American journal of tropical medicine and hygiene.

[41]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[42]  David Eisenberg,et al.  The helical hydrophobic moment: a measure of the amphiphilicity of a helix , 1982, Nature.

[43]  P. Y. Chou,et al.  Prediction of protein conformation. , 1974, Biochemistry.

[44]  S. Lowey,et al.  Substructure of the myosin molecule. I. Subfragments of myosin by enzymic degradation. , 1969, Journal of molecular biology.

[45]  R. B. Merrifield.  Solid phase peptide synthesis. I. the synthesis of a tetrapeptide , 1963 .

[46]  A. Nisonoff,et al.  Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. , 1960, Archives of biochemistry and biophysics.